A membrane leucine heptad contributes to trafficking, signaling, and transformation by latent membrane protein 1

Journal of Virology

Volumn 81, Issue 17, 2007, Pages 9121-9130

  Lee, Jisook ^a   Sugden, Bill ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CD40 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LATENT MEMBRANE PROTEIN 1; LEUCINE; LIGAND; PROTEIN LZ1; UNCLASSIFIED DRUG;

ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; B LYMPHOCYTE; CELL MEMBRANE; CELL PROLIFERATION; CELL SURFACE; CELL TRANSFORMATION; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENETIC TRANSFECTION; GOLGI COMPLEX; HUMAN; HUMAN CELL; LIPID RAFT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; VIRUS CELL INTERACTION; VIRUS GENOME; WILD TYPE;

AMINO ACID SUBSTITUTION; B-LYMPHOCYTES; CELL LINE; CELL TRANSFORMATION, VIRAL; DNA, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; MEMBRANE MICRODOMAINS; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; MUTAGENESIS, SITE-DIRECTED; NF-KAPPA B; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; VIRAL MATRIX PROTEINS;

HUMAN HERPESVIRUS 4;

EID: 34548166979     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00136-07     Document Type: Article

References (45)

1. Brodeur, S. R., G. Cheng, D. Baltimore, and D. A. Thorley-Lawson. 1997. Localization of the major NF-κB-activating site and the sole TRAF3 binding site of LMP-1 defines two distinct signaling motifs. J. Biol. Chem. 272:19777-19784.
2. Brown, D. A., and J. K. Rose. 1992. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell 68:533-544.
3. Brown, K. D., B. S. Hostager, and G. A. Bishop. 2001. Differential signaling and tumor necrosis factor receptor-associated factor (TRAF) degradation mediated by CD40 and the Epstein-Barr virus oncoprotein latent membrane protein 1 (LMP1). J. Exp. Med. 193:943-954.
4. Campbell, R. E., O. Tour, A. E. Palmer, P. A. Steinbach, G. S. Baird, D. A. Zacharias, and R. Y. Tsien. 2002. A monomeric red fluorescent protein. Proc. Natl. Acad. Sci. USA 99:7877-7882.
5. Clausse, B., K. Fizazi, V. Walczak, C. Tetaud, J. Wiels, T. Tursz, and P. Busson. 1997. High concentration of the EBV latent membrane protein 1 in glycosphingolipid-rich complexes from both epithelial and lymphoid cells. Virology 228:285-293.
6. Coffin, W. F., III, K. D. Erickson, M. Hoedt-Miller, and J. M. Martin. 2001. The cytoplasmic amino-terminus of the Latent Membrane Protein-1 of Epstein-Barr virus: relationship between transmembrane orientation and effector functions of the carboxy-terminus and transmembrane domain. Oncogene 20:5313-5330.
7. Coffin, W. F., III, T. R. Geiger, and J. M. Martin. 2003. Transmembrane domains 1 and 2 of the latent membrane protein 1 of Epstein-Barr virus contain a lipid raft targeting signal and play a critical role in cytostasis. J. Virol. 77:3749-3758.
8. Counter, C. M., F. M. Botelho, P. Wang, C. B. Harley, and S. Bacchetti. 1994. Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. J. Virol. 68:3410-3414.
9. Crawford, D. H. 2001. Biology and disease associations of Epstein-Barr virus. Phil. Trans. R. Soc. Lond. B 356:461-473.
10. Delecluse, H. J., T. Hilsendegen, D. Pich, R. Zeidler, and W. Hammerschmidt. 1998. Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells. Proc. Natl. Acad. Sci. USA 95:8245-8250.
11. Devergne, O., E. D. Cahir McFarland, G. Mosialos, K. M. Izumi, C. F. Ware, and E. Kieff. 1998. Role of the TRAF binding site and NF-κB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression. J. Virol. 72:7900-7908.
12. Dirmeier, U., R. Hoffmann, E. Kilger, U. Schultheiss, C. Briseno, O. Gires, A. Kieser, D. Eick, B. Sugden, and W. Hammerschmidt. 2005. Latent membrane protein 1 of Epstein-Barr virus coordinately regulates proliferation with control of apoptosis. Oncogene 24:1711-1717.
13. Dirmeier, U., B. Neuhierl, E. Kilger, G. Reisbach, M. L. Sandberg, and W. Hammerschmidt. 2003. Latent membrane protein 1 is critical for efficient growth transformation of human B cells by Epstein-Barr virus. Cancer Res. 63:2982-2989.
14. Edidin, M. 2001. Shrinking patches and slippery rafts: scales of domains in the plasma membrane. Trends Cell Biol. 11:492-496.
15. Eliopoulos, A. G., and A. B. Rickinson. 1998. Epstein-Barr virus: LMP1 masquerades as an active receptor. Curr. Biol. 8:R196-R198.
16. Gires, O., F. Kohlhuber, E. Kilger, M. Baumann, A. Kieser, C. Kaiser, R. Zeidler, B. Scheffer, M. Ueffing, and W. Hammerschmidt. 1999. Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins. EMBO J. 18:3064-3073.
17. Gurezka, R., R. Laage, B. Brosig, and D. Langosch. 1999. A heptad motif of leucine residues found in membrane proteins can drive self-assembly of artificial transmembrane segments. J. Biol. Chem. 274:9265-9270.
18. Higuchi, M., K. M. Izumi, and E. Kieff. 2001. Epstein-Barr virus latent-infection membrane proteins are palmitoylated and raft-associated: protein 1 binds to the cytoskeleton through TNF receptor cytoplasmic factors. Proc. Natl. Acad. Sci. USA 98:4675-4680.
19. Izumi, K. M., and E. D. Kieff. 1997. The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-κB. Proc. Natl. Acad. Sci. USA 94:12592-12597.
20. Kavathas, P., F. H. Bach, and R. DeMars. 1980. Gamma ray-induced loss of expression of HLA and glyoxalase I alleles in lymphoblastoid cells. Proc. Natl. Acad. Sci. USA 77:4251-4255.
21. Kaye, K. M., O. Devergne, J. N. Harada, K. M. Izumi, R. Yalamanchili, E. Kieff, and G. Mosialos. 1996. Tumor necrosis factor receptor associated factor 2 is a mediator of NF-κB activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein. Proc. Natl. Acad. Sci. USA 93:11085-11090.
22. Kaye, K. M., K. M. Izumi, and E. Kieff. 1993. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc. Natl. Acad. Sci. USA 90:9150-9154.
23. Kaykas, A., K. Worringer, and B. Sugden. 2001. CD40 and LMP-1 both signal from lipid rafts but LMP-1 assembles a distinct, more efficient signaling complex. EMBO J. 20:2641-2654.
24. Kaykas, A., K. Worringer, and B. Sugden. 2002. LMP-1's transmembrane domains encode multiple functions required for LMP-1's efficient signaling. J. Virol. 76:11551-11560.
25. Kieser, A., E. Kilger, O. Gires, M. Ueffing, W. Kolch, and W. Hammerschmidt. 1997. Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade. EMBO J. 16:6478-6485.
26. Lam, N., M. L. Sandberg, and B. Sugden. 2004. High physiological levels of LMP1 result in phosphorylation of eIF2 alpha in Epstein-Barr virus-infected cells. J. Virol. 78:1657-1664.
27. Lam, N., and B. Sugden. 2003. CD40 and its viral mimic, LMP1: similar means to different ends. Cell Signal. 15:9-16.
28. Lam, N., and B. Sugden. 2003. LMP1, a viral relative of the TNF receptor family, signals principally from intracellular compartments. EMBO J. 22:3027-3038.
29. Lawrence, J. B., C. A. Villnave, and R. H. Singer. 1988. Sensitive, high-resolution chromatin and chromosome mapping in situ: presence and orientation of two closely integrated copies of EBV in a lymphoma line. Cell 52:51-61.
30. Liu, H. P., C. C. Wu, and Y. S. Chang. 2006. PRA1 promotes the intracellular trafficking and NF-κB signaling of EBV latent membrane protein 1. EMBO J. 25:4120-4130.
31. Melkonian, K. A., A. G. Ostermeyer, J. Z. Chen, M. G. Roth, and D. A. Brown. 1999. Role of lipid modifications in targeting proteins to detergent-resistant membrane rafts. Many raft proteins are acylated, while few are prenylated. J. Biol. Chem. 274:3910-3917.
32. Munro, S. 2003. Lipid rafts: elusive or illusive? Cell 115:377-388.
33. Myles Hollander, D. A. W. 1999. A distribution-free test for the slope of the regression line (Theil), p. 416-420. In N. A. C. C. V. Barnett, N. I. Fisher, I. M. Johnstone, J. B. Kadanae, D. G. Kendall, D. W. Scott, B. W. Silverman, A. F. M. Smith, and J. L. Teugels (ed.), Nonparametric statistical methods, 2nd ed. Wiley-Interscience Publications, New York, NY.
34. Rickinson, A. B., and E. Keiff. 1996. Epstein-Barr Virus, p. 2397-2446. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, vol. 2. Lippencott Raven, New York, NY.
35. Sandberg, M., W. Hammerschmidt, and B. Sugden. 1997. Characterization of LMP-1's association with TRAF1, TRAF2, and TRAF3. J. Virol. 71:4649-4656.
36. Schutze, S., T. Machleidt, D. Adam, R. Schwandner, K. Wiegmann, M. L. Kruse, M. Heinrich, M. Wickel, and M. Kronke. 1999. Inhibition of receptor internalization by monodansylcadaverine selectively blocks p55 tumor necrosis factor receptor death domain signaling. J. Biol. Chem. 274:10203-10212.
37. Sengupta, S., J. A. den Boon, I. H. Chen, M. A. Newton, D. B. Dahl, M. Chen, Y. J. Cheng, W. H. Westra, C. J. Chen, A. Hildesheim, B. Sugden, and P. Ahlquist. 2006. Genome-wide expression profiling reveals EBV-associated inhibition of MHC class I expression in nasopharyngeal carcinoma. Cancer Res. 66:7999-8006.
38. Shaw, G., S. Morse, M. Ararat, and F. L. Graham. 2002. Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. FASEB J. 16:869-871.
39. Soni, V., T. Yasui, E. Cahir-McFarland, and E. Kieff. 2006. LMP1 transmembrane domain 1 and 2 (TM1-2) FWLY mediates intermolecular interactions with TM3-6 to activate NF-κB. J. Virol. 80:10787-10793.
40. Stang, E., L. E. Johannessen, S. L. Knardal, and I. H. Madshus. 2000. Polyubiquitination of the epidermal growth factor receptor occurs at the plasma membrane upon ligand-induced activation. J. Biol. Chem. 275:13940-13947.
41. Sugimoto, M., H. Tahara, T. Ide, and Y. Furuichi. 2004. Steps involved in immortalization and tumorigenesis in human B-lymphoblastoid cell lines transformed by Epstein-Barr virus. Cancer Res. 64:3361-3364.
42. Yasui, T., M. Luftig, V. Soni, and E. Kieff. 2004. Latent infection membrane protein transmembrane FWLY is critical for intermolecular interaction, raft localization, and signaling. Proc. Natl. Acad. Sci. USA 101:278-283.
43. Young, L. S., and A. B. Rickinson. 2004. Epstein-Barr virus: 40 years on. Nat. Rev. Cancer 4:757-768.
44. Zacharias, D. A., J. D. Violin, A. C. Newton, and R. Y. Tsien. 2002. Partitioning of lipid-modified monomeric GFPs into membrane microdomains of live cells. Science 296:913-916.
45. Zarnegar, B., J. Q. He, G. Oganesyan, A. Hoffmann, D. Baltimore, and G. Cheng. 2004. Unique CD40-mediated biological program in B cell activation requires both type 1 and type 2 NF-κB activation pathways. Proc. Natl. Acad. Sci. USA 101:8108-8113.